Skandinaviska Enskilda Banken (SEB)’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.8K | Hold |
144
| – | – | ﹤0.01% | 820 |
|
|
2025
Q1 | $21.7K | Sell |
144
-9,144
| -98% | -$1.38M | ﹤0.01% | 798 |
|
|
2024
Q4 | $1.7M | Hold |
9,288
| – | – | 0.01% | 600 |
|
|
2024
Q3 | $1.83M | Sell |
9,288
-64,095
| -87% | -$12.6M | 0.01% | 602 |
|
|
2024
Q2 | $15.2M | Sell |
73,383
-37,781
| -34% | -$7.8M | 0.07% | 204 |
|
|
2024
Q1 | $30.1M | Sell |
111,164
-297
| -0.3% | -$80.5K | 0.15% | 124 |
|
|
2023
Q4 | $26.3M | Hold |
111,461
| – | – | 0.15% | 132 |
|
|
2023
Q3 | $21.8M | Sell |
111,461
-23
| -0% | -$4.51K | 0.14% | 145 |
|
|
2023
Q2 | $23.4M | Sell |
111,484
-2,480
| -2% | -$521K | 0.15% | 135 |
|
|
2023
Q1 | $23M | Sell |
113,964
-793
| -0.7% | -$160K | 0.16% | 135 |
|
|
2022
Q4 | $25M | Buy |
114,757
+570
| +0.5% | +$124K | 0.19% | 124 |
|
|
2022
Q3 | $22.5M | Buy |
114,187
+19,577
| +21% | +$3.85M | 0.17% | 122 |
|
|
2022
Q2 | $20.2M | Buy |
94,610
+13,889
| +17% | +$2.97M | 0.15% | 139 |
|
|
2022
Q1 | $22.9M | Buy |
80,721
+10,207
| +14% | +$2.9M | 0.13% | 146 |
|
|
2021
Q4 | $26.5M | Sell |
70,514
-7,568
| -10% | -$2.84M | 0.14% | 143 |
|
|
2021
Q3 | $32.2M | Buy |
78,082
+64,665
| +482% | +$26.7M | 0.18% | 128 |
|
|
2021
Q2 | $4.96M | Buy |
13,417
+7,911
| +144% | +$2.93M | 0.03% | 423 |
|
|
2021
Q1 | $1.6M | Buy |
5,506
+336
| +6% | +$97.4K | 0.01% | 723 |
|
|
2020
Q4 | $1.29M | Sell |
5,170
-277
| -5% | -$69.2K | 0.01% | 762 |
|
|
2020
Q3 | $1.23M | Buy |
5,447
+5,324
| +4,328% | +$1.21M | 0.01% | 688 |
|
|
2020
Q2 | $21K | Buy |
+123
| New | +$21K | ﹤0.01% | 1015 |
|